oxaprozin

Generic: oxaprozin

Labeler: sola pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxaprozin
Generic Name oxaprozin
Labeler sola pharmaceuticals, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

oxaprozin 300 mg/1

Manufacturer
SOLA Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70512-787
Product ID 70512-787_450f5941-7f11-42fe-e063-6394a90a4803
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA217927
Listing Expiration 2026-12-31
Marketing Start 2025-12-03

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70512787
Hyphenated Format 70512-787

Supplemental Identifiers

RxCUI
2668162
UPC
0370512787608
UNII
MHJ80W9LRB
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxaprozin (source: ndc)
Generic Name oxaprozin (source: ndc)
Application Number NDA217927 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (70512-787-60)
source: ndc

Packages (1)

70512-787-60 60 CAPSULE in 1 BOTTLE (70512-787-60)

Ingredients (1)

oxaprozin (300 mg/1)

Linked Drug Pages (1)

Oxaprozin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "450f5941-7f11-42fe-e063-6394a90a4803", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0370512787608"], "unii": ["MHJ80W9LRB"], "rxcui": ["2668162"], "spl_set_id": ["450f5941-7f10-42fe-e063-6394a90a4803"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["SOLA Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (70512-787-60)", "package_ndc": "70512-787-60", "marketing_start_date": "20251203"}], "brand_name": "Oxaprozin", "product_id": "70512-787_450f5941-7f11-42fe-e063-6394a90a4803", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "70512-787", "generic_name": "Oxaprozin", "labeler_name": "SOLA Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "300 mg/1"}], "application_number": "NDA217927", "marketing_category": "NDA", "marketing_start_date": "20251203", "listing_expiration_date": "20261231"}